Industry Showcase Presented by FCI during AAO Virtual Meeting.
William R. Katowitz, MD presents Masterka® study results and Reynaldo M. Javate, MD, FICS presents Masterka® experience and the upcoming world premiere LacriJet® "pushed" monocanalicular stent.
LacriJet® is FCI latest and exclusive preloaded & self-retaining monocanalicular nasolacrimal intubation indicated for epiphora, congenital nasolacrimal duct obstruction and canalicular laceration.
Learn more at:
🌐 fciworldwide.com/products/lac...
🇺🇸 fci-ophthalmics.com/products/...
Masterka® is FCI innovative solution for the treatment of congenital nasolacrimal duct obstruction resistant to probing. Unlike the traditional "pulled" technique, Masterka® has no metallic probe or suture attached to it and is therefore not pulled out of the nose.
Learn more at:
🌐 fciworldwide.com/products/mas...
🇺🇸 fci-ophthalmics.com/products/...
Follow us on LinkedIn:
🖥️ / fci-ophthalmics